The aim of this commentary was to discuss from a rehabilitation perspective the published Cochrane Review 'Sulthiame add-on therapy for epilepsy' 1 by Bresnahan et al., under the direct supervision of the Cochrane Epilepsy Group. This Cochrane Corner is produced in agreement with Developmental Medicine & Child Neurology by Cochrane Rehabilitation.